ENERGY METABOLISM

能量代谢

基本信息

项目摘要

The overall objective of this research component is to investigate the high-energy biochemical mechanisms whereby the perinatal brain is damaged by hypoxia-ischemia and how brain injury can be prevented or reduced through specific modalities of therapy. Specific Aims include: 1) to characterize the earliest alterations in high-energy phosphate reserves which occur during perinatal cerebral hypoxia-ischemia and to correlate these changes with perturbations in cerebral energy utilization, cerebral glucose utilization, glutamate and nitric oxide neurotoxicity, and intracellular calcium accumulation; 2) to correlate the concentrations in cerebral high-energy phosphate reserves and the changes which occur during hypoxia-ischemia using 31P magnetic resonance (MR) spectroscopic methods and enzymatic, fluorometric techniques; 3) to characterize the secondary (delayed) energy failure which occurs during recovery from perinatal cerebral hypoxia-ischemia and to correlate the alterations with the presence and severity of hypoxia-ischemic brain damage; 4) to ascertain underlying biochemical mechanisms whereby the glucocorticosteroid, dexamethasone, protects the perinatal brain from hypoxic-ischemic damage; 5) to determine the protective influence of magnesium sulfate on perinatal hypoxic-ischemic brain damage and, if so, to ascertain its mechanism of action; and 6) to investigate further the presence and extend of alterations in diffusion-weighted and T2-weighted imaging during recovery from perinatal cerebral hypoxia-ischemia and to correlate any changes with the nature and extent of cerebral edema and associated neuropathologic alterations. Seven-days postnatal rats will undergo unilateral cerebral hypoxia-ischemia, during and following which the animals will undergo those procedures necessary to obtain sequential 31P and 1H NMR spectra which will allow for measurements of the alterations in high-energy phosphate reserves and other metabolites which result from the insult. Other animals will undergo MR imaging at specific intervals following cerebral hypoxia-ischemia. Other experiments will elucidate the neuroprotective effect of dexamethasone, magnesium sulfate, and L-NAME on hypoxic-ischemic brain damage in the developing rat. Analytic procedures will include sequential measures with NMR spectroscopy as well as brain tissue analysis of high-energy phosphate reserves and other metabolites using enzymatic, fluorometric techniques.
本研究的总体目标是研究围产期大脑因缺氧缺血而受损的高能生化机制,以及如何通过特定的治疗方式预防或减少脑损伤。具体目的包括:1)描述围产期脑缺氧缺血时高能磷酸盐储备的最早变化,并将这些变化与脑能量利用、脑葡萄糖利用、谷氨酸和一氧化氮神经毒性以及细胞内钙蓄积的扰动联系起来;2)利用31P磁共振(MR)光谱方法和酶、荧光技术,将脑高能磷酸盐储备浓度与缺氧缺血时发生的变化联系起来;3)分析围产期脑缺氧缺血恢复过程中继发性(延迟性)能量衰竭的特征,并将其与缺氧缺血性脑损伤的存在和严重程度联系起来;4)确定糖皮质激素地塞米松保护围产期大脑免受缺氧缺血性损伤的潜在生化机制;5)确定硫酸镁对围产期缺氧缺血性脑损伤的保护作用,如果有,确定其作用机制;6)进一步研究围产期脑缺氧缺血恢复期间弥散加权和t2加权成像改变的存在和范围,并将任何改变与脑水肿的性质和程度以及相关的神经病理改变联系起来。出生后7天的大鼠将接受单侧脑缺氧缺血,在此期间和之后,动物将接受必要的程序,以获得连续的31P和1H核磁共振光谱,这将允许测量高能磷酸盐储备和其他代谢物的变化,这些变化是由侮辱引起的。其他动物将在脑缺氧缺血后的特定时间间隔进行磁共振成像。其他实验将阐明地塞米松、硫酸镁和L-NAME对发育大鼠缺氧缺血性脑损伤的神经保护作用。分析程序将包括核磁共振光谱的顺序测量,以及使用酶、荧光技术对脑组织的高能磷酸盐储备和其他代谢物进行分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL B SMITH其他文献

MICHAEL B SMITH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL B SMITH', 18)}}的其他基金

High Field MRI: Limitations and Solutions
高场 MRI:局限性和解决方案
  • 批准号:
    6669175
  • 财政年份:
    2002
  • 资助金额:
    $ 15.82万
  • 项目类别:
High Field MRI: Limitations and Solutions
高场 MRI:局限性和解决方案
  • 批准号:
    6942693
  • 财政年份:
    2002
  • 资助金额:
    $ 15.82万
  • 项目类别:
High Field MRI: Limitations and Solutions
高场 MRI:局限性和解决方案
  • 批准号:
    6790031
  • 财政年份:
    2002
  • 资助金额:
    $ 15.82万
  • 项目类别:
High Field MRI: Limitations and Solutions
高场 MRI:局限性和解决方案
  • 批准号:
    6555575
  • 财政年份:
    2002
  • 资助金额:
    $ 15.82万
  • 项目类别:
GORDON RESEARCH CONFERENCE ON IN VIVO MAGNETIC RESONANCE
戈登体内磁共振研究会议
  • 批准号:
    6230865
  • 财政年份:
    2000
  • 资助金额:
    $ 15.82万
  • 项目类别:
CORE--MR SPECTROSCOPY /IMAGING FACILITY
核心——MR光谱/成像设备
  • 批准号:
    6318360
  • 财政年份:
    2000
  • 资助金额:
    $ 15.82万
  • 项目类别:
CORE--MR SPECTROSCOPY /IMAGING FACILITY
核心——MR光谱/成像设备
  • 批准号:
    6108707
  • 财政年份:
    1999
  • 资助金额:
    $ 15.82万
  • 项目类别:
ENERGY METABOLISM
能量代谢
  • 批准号:
    6108702
  • 财政年份:
    1999
  • 资助金额:
    $ 15.82万
  • 项目类别:
ENERGY METABOLISM
能量代谢
  • 批准号:
    6272281
  • 财政年份:
    1998
  • 资助金额:
    $ 15.82万
  • 项目类别:
CORE--MR SPECTROSCOPY
核心--MR光谱
  • 批准号:
    6272286
  • 财政年份:
    1998
  • 资助金额:
    $ 15.82万
  • 项目类别:

相似海外基金

Development of small extracellular vesicle agent against brain edema after stroke
抗脑卒中后脑水肿小细胞外囊泡剂的研制
  • 批准号:
    22K09256
  • 财政年份:
    2022
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ethanol disturbes inchemic brain edema
乙醇扰乱缺血性脑水肿
  • 批准号:
    18K10125
  • 财政年份:
    2018
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiological investigation of cytokines and chemokines playing a role in the mechanism of developing brain edema
细胞因子和趋化因子在脑水肿发生机制中的病理生理学研究
  • 批准号:
    18K17417
  • 财政年份:
    2018
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of novel astrocyte-targeted drugs against brain edema and neuronal injury
开发针对脑水肿和神经元损伤的新型星形胶质细胞靶向药物
  • 批准号:
    18K06695
  • 财政年份:
    2018
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Using RNAi techniques, practical use for control of brain edema with aquaporin regulation
利用RNAi技术,通过水通道蛋白调节控制脑水肿的实际应用
  • 批准号:
    18K08835
  • 财政年份:
    2018
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Preventing brain edema involved with astrocyte expansion due to its potassium intake
预防与星形胶质细胞因摄入钾而扩张有关的脑水肿
  • 批准号:
    17K11583
  • 财政年份:
    2017
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the brain edema therapeutics based on a characteristic for AQP11
基于AQP11特性的脑水肿疗法的开发
  • 批准号:
    17K10851
  • 财政年份:
    2017
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppressive effects of GOREI-SAN (Kampo) for brain edema and inflammatory response in acute phase after status epilepticus
GOREI-SAN(汉方)对癫痫持续状态急性期脑水肿和炎症反应的抑制作用
  • 批准号:
    17K08356
  • 财政年份:
    2017
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a new therapy for brain edema: study for regulation of AQP4 as a molecular target
脑水肿新疗法的开发:以 AQP4 作为分子靶标的调节研究
  • 批准号:
    15H04688
  • 财政年份:
    2015
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical use of functional regulation of aquaporin for brain edema decrease using knockdown technique
敲低技术水通道蛋白功能调节减轻脑水肿的临床应用
  • 批准号:
    15K10526
  • 财政年份:
    2015
  • 资助金额:
    $ 15.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了